Metropolis targets 27-28% EBITDA margin via selective M&A
Metropolis Healthcare is sharpening its acquisition strategy and expanding into smaller towns, preventive healthcare adjacencies and specialty diagnostics, targeting 27-28% EBITDA margin over the next three years.
Metropolis Healthcare is sharpening its acquisition strategy as it prepares for its next phase of growth, while also expanding into smaller towns, preventive healthcare adjacencies and specialty diagnostics, with a target of lifting EBITDA margins to 27-28 percent over the next three years, managem…